Logo

Logo

NITI Aayog

Covaxin may get WHO approval by month-end, says NITI Aayog

"We must give time to WHO to make their decisions based on science. However, we hope that these decisions can be taken quickly because people who are receiving Covaxin have certain imperatives of travel. Most of us, who chose the concurrency, is important in terms of licensure. We are hoping for an early decision,"

WHO nod to Covaxin by month-end: Niti Aayog

The WHO approval for emergency use of Covaxin will not only declare it safe for use in other countries but will also enable people receiving the shot to travel abroad without mandatory quarantine, he said.